After the announcement of the reciperochl tariff, where there was a huge decline in other stocks around the world including the IT sector, the shares of pharmaceutics were seen to be a shift. But now this happiness is not going to stay for long. Such a boom showed because the Trump administration had kept pharma separate from the tariff. But after the bounce in the shares of the pharma sector, now the question is arising whether the Trump administration is considering putting tariffs on it?
This is indicated by President Donald Trump himself. President Trump replied to the reporters in the Air Force One, saying that the pharma will start soon and I think it would not have been thought that would not have been thought.
After this indication, the stock of pharmaceutics crashed in the morning at around 11.15 am. The Nifty Pharma Index has suffered the most. Its index fell nearly four and a half percent, while Arbindo Pharma, Lupine and IPCA Labs shares slipped about six percent.
Trump said that we are seeing pharma as a separate category and will announce it in future. Earlier, Caroline Levit, who has been serving a white house secretary since 20 January 2025 in Trump administration, also indicated that the pharmaceuticals were being considered.
He further said that we are getting our important supply chain outsourced from outside. Would we like our life -saving medicines in China or in America? This is a common sense policy.
It is worth noting that on behalf of Donald Trump, on April 2, the US business partner countries announced a tariff. He has announced to impose 26 percent discounted tariffs over India. India, currently about 52 percent tariffs on America.
Trump’s move is being criticized worldwide. In response, many countries including many Canada, China have announced to impose reply on America. On the other hand, experts are expecting the frightening result ahead of it. They believe that in the coming days, not only the trade war will sprinkle, but there is a danger of recession.
Also read: Which formula is the formula that the Trump administration has imposed 27% tariff on India and 34% tariff on China

